Asparagine and Glutamine Deprivation Alters Ionizing Radiation Response, Migration and Adhesion of a p53null Colorectal Cancer Cell Line
Authors:
- Isabella GuardamagnaIGIsabella Guardamagna
- Ombretta IariaOIOmbretta Iaria
- Leonardo LonatiLLLeonardo Lonati
- Alice MentanaAMAlice Mentana
- Andrea PrevitaliAPAndrea Previtali
- Virginia UggèVUVirginia Uggè
- Giovanni Battista IvaldiGIGiovanni Battista Ivaldi
- Marco LiottaMLMarco Liotta
- Paola Tabarelli de FatisPFPaola Tabarelli de Fatis
- Claudia ScottiClaudia Scotti
- Greta PessinoGPGreta Pessino
- Maristella MaggiMMMaristella Maggi
Open Access
- 3 February 2023
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (3) , 2983
Abstract
Colorectal cancer (CRC) is the most prominent form of colon cancer for both incidence (38.7 per 100,000 people) and mortality (13.9 per 100,000 people). CRC’s poor response to standard therapies is linked to its high heterogeneity and complex genetic background. Dysregulation or depletion of the tumor suppressor p53 is involved in CRC transformation and its capability to escape therapy, with p53null cancer subtypes known, in fact, to have a poor prognosis. In such a context, new therapeutic approaches aimed at reducing CRC proliferation must be investigated. In clinical practice, CRC chemotherapy is often combined with radiation therapy with the aim of blocking the expansion of the tumor mass or removing residual cancer cells, though contemporary targeting of amino acid metabolism has not yet been explored. In the present study, we used the p53null Caco-2 model cell line to evaluate the effect of a possible combination of radiation and L-Asparaginase (L-ASNase), a protein drug that blocks cancer proliferation by impairing asparagine and glutamine extracellular supply. When L-ASNase was administered immediately after IR, we observed a reduced proliferative capability, a delay in DNA-damage response and a reduced capability to adhere and migrate. Our data suggest that a correctly timed combination of X-rays and L-ASNase treatment could represent an advantage in CRC therapy.Keywords
Funding Information
- Italian Ministry of Education, University and Research (MIUR)
This publication has 39 references indexed in Scilit:
- Asparaginase induces apoptosis and cytoprotective autophagy in chronic myeloid leukemia cellsOncotarget, 2015
- p53mutations in colorectal cancer- molecular pathogenesis and pharmacological reactivationWorld Journal of Gastroenterology, 2015
- Most hydrogen peroxide-induced histone H2AX phosphorylation is mediated by ATR and is not dependent on DNA double-strand breaksThe Journal of Biochemistry, 2014
- Hydroxytyrosol suppresses MMP-9 and COX-2 activity and expression in activated human monocytes via PKCα and PKCβ1 inhibitionAtherosclerosis, 2014
- PI3-K/Akt/JNK/NF-κB is essential for MMP-9 expression and outgrowth in human limbal epithelial cells on intact amniotic membraneStem Cell Research, 2012
- ERK and Akt signaling pathways function through parallel mechanisms to promote mTORC1 signalingAmerican Journal of Physiology-Cell Physiology, 2011
- γH2AX: a sensitive molecular marker of DNA damage and repairLeukemia, 2010
- H2AX Phosphorylation: Its Role in DNA Damage Response and Cancer TherapyJournal of Nucleic Acids, 2010
- GCN2 Protein Kinase Is Required to Activate Amino Acid Deprivation Responses in Mice Treated with the Anti-cancer Agent l-AsparaginaseJournal of Biological Chemistry, 2009
- H2AX phosphorylation within the G 1 phase after UV irradiation depends on nucleotide excision repair and not DNA double-strand breaksProceedings of the National Academy of Sciences, 2006